HALEOSLABS.NSNSE
Haleos Labs Limited
₹1556.80
ListedAug 18, 2017
SectorHealthcare
IndustryBiotechnology
CountryIndia
Employees592
State-| CityHyderabad| AddressPlot No. 19-III| Phone91 40 6628 8888
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
23.7
?
Div. Rate
₹1.50
?
Div. Yield
0.09%
?
Payout Ratio
2.28%
?
Max Consec. Div. Years
5 years
?
Longest Consec. Div.
5 years
?
Div. Coverage
75%
?
Div. Stability Rate
0.00
?
Div. Growth Rate
0.00%
?
Score
64

Dividend History

Historical dividend payments by ex-dividend date.

Sep 24, 2025
₹ 1.5000
Sep 23, 2024
₹ 1.5000
Sep 22, 2023
₹ 1.5000
Sep 22, 2022
₹ 1.5000
Sep 20, 2021
₹ 1.5000
Sep 19, 2019
₹ 1.5000

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!